Can gabapentin or nortriptyline be prescribed for a patient with multiple myeloma and moderate renal impairment (estimated creatinine clearance ~35 mL/min)?

Can Gabapentin and Nortriptyline Be Given in Multiple Myeloma with Moderate Renal Impairment?

Yes, both gabapentin and nortriptyline can be prescribed for a patient with multiple myeloma and moderate renal impairment (CrCl ~35 mL/min), but gabapentin requires mandatory dose reduction while nortriptyline does not require renal dose adjustment.

Gabapentin in Moderate Renal Impairment

Gabapentin is safe and effective in moderate renal impairment but requires strict dose adjustment based on creatinine clearance. 1

Specific Dosing for CrCl ~35 mL/min

For a patient with CrCl of 35 mL/min (falling in the 30-59 mL/min range), the FDA-approved dosing is 2:

• Total daily dose range: 400-1400 mg/day
• Dosing regimen options:
  • 200 mg twice daily
  • 300 mg twice daily
  • 400 mg twice daily
  • 500 mg twice daily
  • 700 mg twice daily

Start at the lower end (200 mg twice daily) and titrate cautiously upward based on efficacy and tolerability. 1 The maximum time between doses should not exceed 12 hours. 2

Critical Monitoring Requirements

• Gabapentin is exclusively eliminated renally and accumulates significantly in renal impairment 3, 4
• Patients with CKD receiving inappropriately high doses develop toxicity in 5.56% of cases, manifesting as encephalopathy, myoclonus, confusion, and sedation 3
• Monitor for early signs of gabapentin toxicity: altered mental status, dizziness, sedation, or unexplained myalgia 3, 5
• If unexplained myalgia occurs with CPK >3× upper limit of normal, consider gabapentin cessation due to rhabdomyolysis risk 5

Pharmacokinetic Considerations

In moderate renal impairment (CrCl 30-60 mL/min), gabapentin half-life increases from 6.5 hours to approximately 20-30 hours, and plasma clearance decreases from 190 mL/min to 50-70 mL/min 2, 4. This necessitates the dose reductions outlined above.

Nortriptyline in Moderate Renal Impairment

Nortriptyline does not require dose adjustment for renal impairment as it is primarily hepatically metabolized, not renally cleared. 1

Standard Dosing Approach

• Starting dose: 25 mg at bedtime
• Titration: Increase by 25 mg every 3-7 days as tolerated
• Maximum dose: 150 mg/day (or continue cautious titration if blood concentration of active medication plus metabolite is <100 ng/mL) 1
• Duration for adequate trial: 6-8 weeks with at least 2 weeks at maximum tolerated dose 1

Important Precautions

• Obtain screening electrocardiogram before initiation (patient likely >40 years old) 1
• Monitor for cardiac conduction abnormalities and avoid in patients with ischemic cardiac disease or ventricular conduction abnormalities 1
• Limit dosages to <100 mg/day when possible in high-risk patients 1

Multiple Myeloma-Specific Considerations

The NCCN and EHA-EMN guidelines emphasize that nephrotoxic medications should be discontinued in MM patients with renal disease 6. However, neither gabapentin nor nortriptyline are considered nephrotoxic agents. In fact:

• Gabapentin is specifically recommended for neuropathic pain management in MM patients 1
• Both medications can provide symptomatic relief for chemotherapy-induced peripheral neuropathy, a common complication in MM treatment

Drug Interaction Vigilance

Critical warning: If the patient is receiving statins (common in MM patients with multiple comorbidities), gabapentin co-administration increases rhabdomyolysis risk 5. Monitor CPK levels if this combination is necessary.

Practical Implementation Algorithm

1. Verify current creatinine clearance using Cockcroft-Gault equation 2
2. For gabapentin:
   • Start 200 mg twice daily (not three times daily as in normal renal function)
   • Titrate slowly over 3-8 weeks
   • Never exceed 1400 mg/day total
   • Monitor for sedation, confusion, or myalgia
3. For nortriptyline:
   • Use standard dosing (25 mg at bedtime, titrate by 25 mg every 3-7 days)
   • Obtain baseline ECG
   • No renal dose adjustment needed
4. Reassess renal function regularly as MM treatment may improve or worsen kidney function, necessitating gabapentin dose adjustments 6

Both medications are appropriate choices for neuropathic pain in this clinical scenario, with gabapentin requiring more careful dose adjustment and monitoring due to renal elimination.